On Monday, Relmada Therapeutics Inc (NASDAQ: RLMD) was 7.39% up from the session before settling in for the closing price of $4.06. A 52-week range for RLMD has been $0.24 – $5.12.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 0.68%. When this article was written, the company’s average yearly earnings per share was at 68.68%. With a float of $63.18 million, this company’s outstanding shares have now reached $73.33 million.
Relmada Therapeutics Inc (RLMD) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Relmada Therapeutics Inc stocks. The insider ownership of Relmada Therapeutics Inc is 13.85%, while institutional ownership is 14.57%. The most recent insider transaction that took place on Nov 05 ’25, was worth 1,100,000. In this transaction Chief Financial Officer of this company bought 500,000 shares at a rate of $2.20, taking the stock ownership to the 788,335 shares. Before that another transaction happened on Nov 05 ’25, when Company’s CAO and COO bought 136,000 for $2.20, making the entire transaction worth $299,200. This insider now owns 403,931 shares in total.
Relmada Therapeutics Inc (RLMD) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 68.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.22% during the next five years compared to 0.68% growth over the previous five years of trading.
Relmada Therapeutics Inc (NASDAQ: RLMD) Trading Performance Indicators
You can see what Relmada Therapeutics Inc (RLMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.36 in one year’s time.
Technical Analysis of Relmada Therapeutics Inc (RLMD)
Compared to the last year’s volume of 1.18 million, its volume of 1.17 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 49.35%.
During the past 100 days, Relmada Therapeutics Inc’s (RLMD) raw stochastic average was set at 83.37%, which indicates a significant increase from 64.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.46 in the past 14 days, which was higher than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.17, while its 200-day Moving Average is $1.32. Nevertheless, the first resistance level for the watch stands at $4.54 in the near term. At $4.71, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.98. If the price goes on to break the first support level at $4.10, it is likely to go to the next support level at $3.83. Now, if the price goes above the second support level, the third support stands at $3.66.
Relmada Therapeutics Inc (NASDAQ: RLMD) Key Stats
There are 73,334K outstanding shares of the company, which has a market capitalization of 319.73 million. As of now, sales total 0 K while income totals -79,980 K. Its latest quarter income was 0 K while its last quarter net income were -10,090 K.
